Vitreous Antioxidants, Degeneration, and Vitreo-Retinopathy: Exploring the Links
- PMID: 31861871
- PMCID: PMC7022282
- DOI: 10.3390/antiox9010007
Vitreous Antioxidants, Degeneration, and Vitreo-Retinopathy: Exploring the Links
Abstract
The transparent vitreous body, which occupies about 80% of the eye's volume, is laden with numerous enzymatic and non-enzymatic antioxidants that could protect the eye from oxidative stress and disease. Aging is associated with degeneration of vitreous structure as well as a reduction in its antioxidant capacity. A growing body of evidence suggests these age-related changes may be the precursor of numerous oxidative stress-induced vitreo-retinopathies, including vision degrading myodesopsia, the clinically significant entoptic phenomena that can result from advanced vitreous degeneration. Adequate intravitreal antioxidant levels may be protective against vitreous degeneration, possibly preventing and even improving vision degrading myodesopsia as well as mitigating various other vitreo-retinopathies. The present article is, therefore, a review of the different antioxidant molecules within vitreous and the inter-relationships between vitreous antioxidant capacity and degeneration.
Keywords: antioxidants; floaters; oxidative stress; vision degrading myodesopsia; vitreous; vitreous degeneration.
Conflict of interest statement
The authors have no conflict of interest in connection with this article. J.S. is a paid consultant to ebiga-VISION GmbH. The funders had no role in the design of the study; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- Kolb H. How the retina works: Much of the construction of an image takes place in the retina itself through the use of specialized neural circuits. Am. Sci. 2003;91:28–35. doi: 10.1511/2003.1.28. - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
